Fermentalg SA (FRA:1F6)

Market Cap	43.80M -6.8%
Revenue (ttm)	13.38M +16.4%
Net Income	-9.44M
EPS	-0.09
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.4500
Previous Close	0.4450
Day's Range	0.4500 - 0.4500
52-Week Range	0.3915 - 0.6290
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 6, 2026

About Fermentalg

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2009
• Employees: 64
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1F6

Financial Performance

In 2025, Fermentalg's revenue was 13.38 million, an increase of 16.41% compared to the previous year's 11.50 million. Losses were -9.44 million, -26.71% less than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error